Groowe / Newsroom / SCYX

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SCYX News

SCYNEXIS, Inc.

SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study

globenewswire.com Oct 15, 2025 2:00 AM

SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)

globenewswire.com Sep 30, 2025 2:00 AM